With a Master’s degree in Organic Chemistry and an ongoing Ph.D. pursuit at JNTU, Hyderabad, Dr. Kodali has laid a strong foundation for his illustrious career. His scholarly achievements are further highlighted by authoring over 50 patent applications, demonstrating a deep commitment to advancing the frontiers of scientific knowledge.
Dr. Eswara Rao Kodali is a seasoned leader and visionary in the field of Organic Chemistry with a rich professional journey spanning over 25 years. As the CEO and Managing Partner, he stands at the helm of innovation, bringing forth a wealth of expertise in Research & Development, particularly in Organic Synthesis & Process Development.
He possesses a remarkable track record in product development, spanning from straightforward chemical molecules to intricately designed compounds with more than 5 chiral centers. Dr. Eswara Rao Kodali has not only successfully filed US Drug Master Files (DMFs) but has also adeptly navigated US FDA Audits. His pivotal role as a key contributor in developing products that meet stringent regulated market requirements is evidenced by numerous DMF filings in both the United States and the European Union.
Dr. Kodali has held pivotal leadership roles, including Vice President (R&D) at Enaltec Labs, where he steered Manufacturing Operations and Research and Development Centre. His transformative initiatives at Matrix, Actavis, and Glenmark underline his ability to pioneer and elevate API divisions into major business units.
Dr. Kodali’s commitment to excellence and innovation continues to shape the landscape of Organic Chemistry and Pharmaceutical Research & Development. Collaborate with him to leverage his wealth of experience and expertise in driving cutting-edge solutions in the ever-evolving pharmaceutical industry.
CHRONOLOGY
2016-Present
Respect Labs LLP - Co-Founder and CEO
2007-2016
ENALTEC Labs - Asst. Vice President R&D
2002-2006
Glenmark Pharmaceutical Ltd - Senior Research Scientist
2001-2002
Matrix Laboratories Ltd(Mylan) - Research Officer